KSP Recognized as a Specialty Pharmacy Leader
KSP, part of McLaren's Specialty Pharmacy, has once again been honored for its outstanding achievements in performance measurement. The Utilization Review Accreditation Commission (URAC) has recognized KSP as a 2024 Specialty Pharmacy Pioneer in its Leaders in Performance Measurement (LPM) program. This accolade underlines KSP's unwavering commitment to enhancing health care quality through meticulous performance assessment.
Commitment to Quality Care
As a premier specialty pharmacy, KSP serves patients with complex medical needs requiring high-cost treatments. This includes critical areas such as cancer, HIV, and various neurological disorders. KSP ensures that patients receive their prescriptions at an affordable cost, aided by various financial assistance programs. Achieving the status of a Pioneer in Performance Measurement means KSP exceeds standard reporting and contributes valuable insights into innovative measurement methodologies.
Team Dedication
Stephen Kaurala, PharmD, MBA, BCOP, who manages KSP, expressed pride in the team's dedication to providing exceptional care. "Our commitment to each patient drives us to deliver beyond expectations," Kaurala remarked. This dedication has propelled KSP to maintain its prestigious status for three consecutive years.
Evaluation and Recognition Process
This recognition signifies KSP's positioning as a leader among specialty pharmacies participating in URAC's LPM programs. The evaluation process assessed data submitted for 2024, collected throughout the previous year. KSP not only met but exceeded several criteria established by URAC, including maintaining full accreditation status and timely submissions of performance measures.
Acknowledging Team Efforts
Surender Kanaparthi, R.Ph., MBA, DPLA, FACHE, chief pharmacy officer at Karmanos Cancer Hospital, commended KSP's efforts in maintaining high standards in patient care. "KSP addresses the specific needs of patients requiring unique medications that local pharmacies may not offer," Kanaparthi explained. The team's dedication to improving health outcomes for McLaren patients has significantly contributed to KSP's outstanding recognition.
Accreditation Success
KSP achieved re-accreditation as a URAC Specialty Pharmacy in the prior year, having first earned this distinction in 2020. KSP underwent rigorous evaluations, focusing on various aspects such as risk management, performance monitoring, and patient management. These evaluations ensure KSP’s operations align with the highest standards in the specialty pharmacy field.
Expanding Services to Patients
As a vital extension of the Barbara Ann Karmanos Cancer Institute under McLaren Health Care, KSP has significantly grown its capabilities to meet the specialty pharmaceutical needs of patients. It provides essential services to patients across multiple states, effectively tailoring its operations to address diverse health challenges.
About McLaren Health Care
McLaren Health Care is a $7.3 billion integrated health care delivery system committed to high-quality patient care backed by evidence. It encompasses 12 hospitals, surgery centers, and a wide array of services, including specialized care through the Karmanos Cancer Institute. This extensive network integrates numerous providers to ensure comprehensive care across several states.
About Karmanos Cancer Institute
The Karmanos Cancer Institute stands out as a leader in cancer research and transformative care, driven by a vision to eliminate cancer. It operates the largest network of cancer facilities in the region, focusing on innovative treatment options supported by academic partnerships, enhancing patient outcomes through comprehensive cancer care.
Frequently Asked Questions
What is KSP's role in patient care?
KSP provides medications for patients with complex diseases, ensuring affordability and access through financial assistance.
How has KSP been recognized in recent years?
KSP has been awarded the URAC recognition as a Specialty Pharmacy Pioneer for three consecutive years for its performance measurement standards.
What does it mean to be a Pioneer in Performance Measurement?
This status indicates that KSP goes beyond the required reporting standards and embraces innovative concepts in performance evaluation.
What criteria did KSP meet to achieve URAC accreditation?
KSP met various important criteria, such as full URAC accreditation status and timely measure submissions.
Who leads KSP and its operations?
Stephen Kaurala serves as the pharmacy manager, guiding the team in delivering exceptional patient care throughout their therapy journeys.
